News

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...
Why This Beef Stew Deserves A Spot In Your Weekly Rotation This isn’t your average beef stew—it’s a rich, creamy, ...
This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.
I messed around and found out how these DIY food dish mash-up taste at New Orleans Jazz Fest. Here's the best of the bunch ...
Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...
The Tigers (22-13) took three of four from the Angels and head into Monday’s off-day with the AL's best record.
Rezdiffra sales reached $137 million for the quarter, beating consensus analyst estimates by more than $20 million and ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
The Laval Rocket returned to a packed Place Bell looking to apply the broom to the Cleveland Monsters in the North Division ...